Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Universal Biotech is a leading Chinese life sciences service provider that specializes in the distribution of research reagents, instruments, and consumables. The company operates a comprehensive e-commerce platform that serves as a centralized marketplace for researchers in academia, healthcare, and the biopharmaceutical industry. Their extensive product portfolio includes over 4 million SKUs, featuring antibodies, proteins, and assay kits from both international brands and their own proprietary labels. In addition to distribution, the company provides integrated technical services such as antibody development, experimental outsourcing, and laboratory automation solutions. Shanghai Universal Biotech is publicly traded on the Shenzhen Stock Exchange and is a critical link in the Chinese life sciences supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Universal Biotech.